Mirum Pharmaceuticals Inc
NASDAQ:MIRM
Mirum Pharmaceuticals Inc
NASDAQ:MIRM
Price:
92.19
USD
-15.13%
Market Cap:
$4.8B
Income Statement
Earnings Waterfall
Mirum Pharmaceuticals Inc
Mirum Pharmaceuticals Inc
Income Statement
Mirum Pharmaceuticals Inc
Mirum Pharmaceuticals Inc
Currency: USD
| Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||||||||
| Interest Expense |
0
|
0
|
0
|
0
|
0
|
4
|
8
|
14
|
18
|
18
|
17
|
15
|
16
|
16
|
16
|
16
|
15
|
14
|
14
|
14
|
14
|
14
|
14
|
14
|
|
| Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
11
N/A
|
16
+45%
|
19
+20%
|
32
+67%
|
39
+20%
|
52
+36%
|
77
+47%
|
96
+24%
|
116
+21%
|
145
+25%
|
186
+29%
|
224
+20%
|
264
+18%
|
307
+16%
|
337
+10%
|
379
+13%
|
429
+13%
|
472
+10%
|
|
| Gross Profit | |||||||||||||||||||||||||
| Cost of Revenue |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(2)
|
(4)
|
(7)
|
(10)
|
(12)
|
(15)
|
(19)
|
(27)
|
(47)
|
(60)
|
(73)
|
(84)
|
(82)
|
(87)
|
(90)
|
(95)
|
|
| Gross Profit |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
17
N/A
|
12
-32%
|
27
+128%
|
43
+59%
|
65
+52%
|
81
+25%
|
97
+19%
|
118
+22%
|
139
+18%
|
164
+18%
|
191
+16%
|
223
+17%
|
255
+14%
|
292
+15%
|
339
+16%
|
377
+11%
|
|
| Operating Income | |||||||||||||||||||||||||
| Operating Expenses |
(55)
|
(71)
|
(80)
|
(86)
|
(104)
|
(130)
|
(155)
|
(181)
|
(191)
|
(78)
|
(76)
|
(77)
|
(196)
|
(206)
|
(215)
|
(229)
|
(248)
|
(322)
|
(300)
|
(319)
|
(343)
|
(369)
|
(396)
|
(419)
|
|
| Selling, General & Administrative |
(12)
|
(15)
|
(18)
|
(20)
|
(23)
|
(27)
|
(36)
|
(47)
|
(59)
|
(69)
|
(76)
|
(82)
|
(89)
|
(100)
|
(112)
|
(126)
|
(146)
|
(161)
|
(177)
|
(192)
|
(202)
|
(215)
|
(229)
|
(240)
|
|
| Research & Development |
(43)
|
(55)
|
(62)
|
(66)
|
(82)
|
(102)
|
(119)
|
(133)
|
(131)
|
(117)
|
(108)
|
(104)
|
(107)
|
(106)
|
(103)
|
(103)
|
(103)
|
(111)
|
(122)
|
(128)
|
(141)
|
(154)
|
(168)
|
(179)
|
|
| Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
108
|
108
|
108
|
0
|
0
|
0
|
0
|
0
|
(49)
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Operating Income |
(55)
N/A
|
(71)
-29%
|
(80)
-14%
|
(86)
-7%
|
(104)
-21%
|
(130)
-25%
|
(144)
-11%
|
(165)
-15%
|
(173)
-5%
|
(51)
+71%
|
(45)
+12%
|
(35)
+22%
|
(131)
-279%
|
(126)
+4%
|
(118)
+6%
|
(111)
+7%
|
(109)
+1%
|
(158)
-44%
|
(108)
+31%
|
(96)
+11%
|
(88)
+9%
|
(76)
+13%
|
(57)
+25%
|
(42)
+27%
|
|
| Pre-Tax Income | |||||||||||||||||||||||||
| Interest Income Expense |
2
|
3
|
3
|
2
|
1
|
(2)
|
(9)
|
(13)
|
(18)
|
(19)
|
(16)
|
(15)
|
(11)
|
(9)
|
(6)
|
(3)
|
(1)
|
1
|
1
|
0
|
(1)
|
(1)
|
(2)
|
(2)
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
108
|
0
|
0
|
0
|
0
|
0
|
(49)
|
(49)
|
(49)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Other Income |
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
1
|
1
|
0
|
(0)
|
(2)
|
(0)
|
(3)
|
(0)
|
0
|
(2)
|
1
|
2
|
1
|
3
|
|
| Pre-Tax Income |
(53)
N/A
|
(68)
-29%
|
(78)
-14%
|
(84)
-8%
|
(103)
-23%
|
(132)
-28%
|
(153)
-16%
|
(179)
-17%
|
(84)
+53%
|
(70)
+17%
|
(60)
+15%
|
(48)
+19%
|
(142)
-195%
|
(135)
+5%
|
(176)
-30%
|
(163)
+7%
|
(162)
+1%
|
(157)
+3%
|
(107)
+32%
|
(98)
+9%
|
(87)
+11%
|
(76)
+13%
|
(57)
+25%
|
(40)
+29%
|
|
| Net Income | |||||||||||||||||||||||||
| Tax Provision |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
7
|
7
|
6
|
6
|
(1)
|
(1)
|
(1)
|
(1)
|
(2)
|
(2)
|
(1)
|
(1)
|
(1)
|
(1)
|
|
| Income from Continuing Operations |
(53)
|
(68)
|
(78)
|
(84)
|
(103)
|
(132)
|
(153)
|
(179)
|
(84)
|
(70)
|
(53)
|
(42)
|
(136)
|
(129)
|
(176)
|
(164)
|
(163)
|
(159)
|
(110)
|
(100)
|
(88)
|
(78)
|
(59)
|
(42)
|
|
| Net Income (Common) |
(53)
N/A
|
(68)
-29%
|
(78)
-14%
|
(84)
-8%
|
(103)
-23%
|
(132)
-28%
|
(153)
-16%
|
(179)
-17%
|
(84)
+53%
|
(70)
+17%
|
(53)
+24%
|
(42)
+21%
|
(136)
-225%
|
(129)
+5%
|
(176)
-36%
|
(164)
+7%
|
(163)
+0%
|
(159)
+3%
|
(110)
+31%
|
(100)
+9%
|
(88)
+12%
|
(78)
+12%
|
(59)
+25%
|
(42)
+29%
|
|
| EPS (Diluted) |
-2.28
N/A
|
-2.74
-20%
|
-3.1
-13%
|
-3.34
-8%
|
-4.09
-22%
|
-4.4
-8%
|
-5.05
-15%
|
-5.88
-16%
|
-2.77
+53%
|
-2.23
+19%
|
-1.65
+26%
|
-1.19
+28%
|
-4.01
-237%
|
-3.42
+15%
|
-4.62
-35%
|
-3.99
+14%
|
-4
0%
|
-3.37
+16%
|
-2.33
+31%
|
-2.08
+11%
|
-1.85
+11%
|
-1.58
+15%
|
-1.17
+26%
|
-0.73
+38%
|
|
Switch to:
Switch to:
See Also
Discover More
